<?xml version='1.0' encoding='utf-8'?>
<document id="29468979"><sentence text="Potentiation of Warfarin Associated with Salsalate Therapy Resulting in Bleeding."><entity charOffset="16-24" id="DDI-PubMed.29468979.s1.e0" text="Warfarin" /><entity charOffset="41-50" id="DDI-PubMed.29468979.s1.e1" text="Salsalate" /><pair ddi="false" e1="DDI-PubMed.29468979.s1.e0" e2="DDI-PubMed.29468979.s1.e0" /><pair ddi="false" e1="DDI-PubMed.29468979.s1.e0" e2="DDI-PubMed.29468979.s1.e1" /></sentence><sentence text="Salsalate may offer many advantages over other non-steroidal antiinflammatory agents in patients taking warfarin, however a drug-drug interaction may occur which has not been reported in the medical literature or by the manufacturer of salsalate"><entity charOffset="0-9" id="DDI-PubMed.29468979.s2.e0" text="Salsalate" /><entity charOffset="236-245" id="DDI-PubMed.29468979.s2.e1" text="salsalate" /><pair ddi="false" e1="DDI-PubMed.29468979.s2.e0" e2="DDI-PubMed.29468979.s2.e0" /><pair ddi="false" e1="DDI-PubMed.29468979.s2.e0" e2="DDI-PubMed.29468979.s2.e1" /></sentence><sentence text="" /><sentence text="To report a case of warfarin potentiation associated with salsalate treatment, which resulted in bleeding"><entity charOffset="58-67" id="DDI-PubMed.29468979.s4.e0" text="salsalate" /></sentence><sentence text="" /><sentence text="Clinical review of the course of a patient, who was stable on warfarin when salsalate therapy was added for chronic pain" /><sentence text="" /><sentence text="A patient taking stable doses of warfarin for over 1 year (with good control) was prescribed salsalate 3 g/day for pain in his knee and lower back" /><sentence text=" Approximately 1 month later he presents to the anticoagulation clinic with bruising and an International Normalized Ratio (INR) of 6" /><sentence text="8" /><sentence text=" The patient had a good response to his salsalate therapy and wanted to continue it" /><sentence text=" The warfarin was held for 3 days and dose lowered by 50 %" /><sentence text=" His bruising then subsided and he had good control of his warfarin therapy with INRs ranging from 1" /><sentence text="9 to 2" /><sentence text="2 over the next 4 months" /><sentence text=" The patient was then lost to follow up" /><sentence text="" /><sentence text="This case illustrates a strong association between starting salsalate and subsequent potentiation of warfarin, which heretofore has not been reported in the medical literature"><entity charOffset="60-69" id="DDI-PubMed.29468979.s18.e0" text="salsalate" /></sentence><sentence text="" /></document>